id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2136-0001,FDA,FDA-2022-E-2136,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-09-06T04:00:00Z,2022,9,2022-09-06T04:00:00Z,,2022-09-06T14:51:55Z,,0,0,09000064852b50d9
FDA-2022-E-2136-0002,FDA,FDA-2022-E-2136,Patent Extension Application from Novartis AG,Other,Application,2022-09-06T04:00:00Z,2022,9,2022-09-06T04:00:00Z,,2022-09-06T14:52:02Z,,0,0,09000064852b50db